Opioid Use Disorder: Opportunities to Improve Assessments of State Opioid Response Grant Program
The Substance Abuse and Mental Health Services Administration (SAMHSA) administers the State Opioid Response Grant program for opioid use disorder prevention, treatment, and recovery services.
SAMHSA assesses the program through 2 annual performance reports. We recommended making such reports more useful by:
- Including assessment limitations: Knowing about any limitations—such as incomplete data—helps decision makers understand and draw reasonable conclusions from the reports
- Further assessing existing data: For example, a look at performance variations across states and demographics could help program managers improve client outcomes
What GAO Found
The State Opioid Response (SOR) grant program provides grants to help address the negative effects of the opioid crisis, including overdose deaths. Through the program, the Substance Abuse and Mental Health Services Administration (SAMHSA) has awarded nearly $5.2 billion since 2018 to states, the District of Columbia, and U.S. territories for opioid-use disorder (OUD) prevention, treatment, and recovery support services.
Examples of Prevention, Treatment, and Recovery Support Services Grantees Provide Using State Opioid Response Grant Program Funding
SAMHSA primarily assesses the SOR grant program through its annual SOR program profile and report to Congress, according to SAMHSA officials. These reports present a high-level national snapshot of SOR program performance, such as nationwide changes in drug abstinence and housing stability among program participants. The report to Congress also describes how grantees are implementing the program, such as describing evidence-based treatments and practices used by grantees.
However, neither the program profile nor the report to Congress provide information on potential limitations associated with the assessments. For example, SAMHSA does not make it clear that the data used for the 2020 profile were incomplete for two-thirds of people participating in the program, which could potentially affect conclusions that could be drawn from this information. SAMHSA is working to improve the completeness of these data, but also identifying potential limitations and their effects on conclusions could help ensure that Congress and others can correctly interpret the data and make more fully informed decisions, such as if changes are necessary to the SOR program.
In addition, the program profile and report to Congress do not fully leverage information available to provide a more in-depth assessment of the SOR program. SAMHSA has the potential to use its existing data to gain further insights into how well the program is working and why. For example, looking for variation in program performance across states and demographic groups could help identify best practices and areas for improvement. Such insights could help identify opportunities to improve program effectiveness and client outcomes, which may help reduce opioid-related overdose deaths and improve the lives of the clients the program serves.
Why GAO Did This Study
The misuse of illicit and prescription drugs, including opioids, has been a long-standing and persistent problem in the U.S., representing a serious risk to public health that has become even greater during the COVID-19 pandemic. Provisional data estimate that drug overdose deaths increased 29 percent in the year ending in April 2021—to a record high of 100,306—with opioid-related overdose deaths making up three-quarters of the total.
SAMHSA leads federal public health efforts to address the opioid crisis, which include administering the SOR grant program, the agency's largest such program since the grant began in 2018.
GAO was asked to review SAMHSA's SOR grant program. This report examines how SAMHSA assesses the grant program, among other things.
GAO reviewed documents relevant to SAMHSA's SOR monitoring and program assessment efforts; interviewed SAMHSA officials; and analyzed documentation for 10 SOR grantees, selected to reflect a range of award amounts.
GAO is making two recommendations, that SAMHSA ensure its SOR grant program assessment efforts (1) identify potential limitations and how those limitations may affect the conclusions that can and cannot be drawn; and (2) further analyze existing program information to provide a more comprehensive, in-depth assessment of the program to identify opportunities for improvement. The Department of Health and Human Services concurred with GAO's recommendations.
Recommendations for Executive Action
|Substance Abuse and Mental Health Services Administration||The Assistant Secretary for Mental Health and Substance Use should ensure that SAMHSA's SOR grant program assessment reports, such as its annual SOR program profile and report to Congress, identify potential limitations in their findings, and describe how any such limitations may affect the conclusions that can and cannot be drawn about the effectiveness of the program. (Recommendation 1)||
SAMHSA concurred with this recommendation. In December 2022, SAMHSA reported that it is working to better leverage programmatic data to assess SOR grantee performance and ensure effectiveness of the program. SAMHSA said this involves a comprehensive approach that includes developing a method to communicate data limitations in SOR grant program assessment reports, profiles, and reports to Congress. Specifically, SAMHSA said it is developing a limitations section for inclusion in SOR grant program assessment reports, profiles, and reports to Congress. The limitations section will identify potential and actual limitations in data collected and report findings, and will describe, when possible, how these limitations might affect the conclusions regarding the SOR program. The limitations may include (but are not limited to) selection bias, incomplete data, and differences in grantee service delivery models. SAMHSA plans to include a limitations section in the upcoming SOR Report to Congress, which SAMHSA anticipates will be delivered to Congress during the third quarter of fiscal year 2023. We will continue to monitor the agency's progress implementing activities that would address the recommendation and provide updates when the agency takes further action.
|Substance Abuse and Mental Health Services Administration||The Assistant Secretary for Mental Health and Substance Use should further analyze existing SOR grant program information, such as by disaggregating data by client groups, to provide a more comprehensive, in-depth assessment of program performance and use such information to identify opportunities for program improvement. (Recommendation 2)||
SAMHSA concurred with this recommendation. In December 2022, SAMHSA reported that it was working to better leverage programmatic data to assess SOR grantee performance and ensure effectiveness of the program. SAMHSA said this involves modifying data collection tools to better assess performance on key programmatic objectives as well as conducting additional analyses of program data. Specifically, SAMHSA said it modified the two Government Performance and Results Act (GPRA) data collection tools that SOR grantees must use to report performance measures. SAMHSA said this would better enable SAMHSA to analyze the impact the SOR program has on clients and populations served by more accurately capturing client demographics, services rendered, and client outcomes. The first revised tool-the SOR/TOR Program Instrument-went into effect on April 1, 2022. SAMHSA anticipated implementing the second revised tool-the Center for Substance Abuse Treatment (CSAT) GPRA Client Outcome Measures for Discretionary Programs tool-on January 4, 2022. In addition to revising its data collection tools, SAMHSA said it is conducting a more robust analysis of its current SOR programmatic data that includes using disaggregated data by client characteristics to provide a more comprehensive, in-depth assessment of program performance. SAMHSA plans to include findings from this analysis in the upcoming SOR Report to Congress and other SAMHSA reports and products. SAMHSA anticipates it will deliver the SOR Report to Congress during the third quarter of fiscal year 2023. We will continue to monitor the agency's progress implementing activities that would address the recommendation and provide updates when the agency takes further action.